These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 31011193)

  • 1. Harnessing cell pluripotency for cardiovascular regenerative medicine.
    Chen H; Zhang A; Wu JC
    Nat Biomed Eng; 2018 Jun; 2(6):392-398. PubMed ID: 31011193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regenerative medicine for the heart: perspectives on stem-cell therapy.
    Cho GS; Fernandez L; Kwon C
    Antioxid Redox Signal; 2014 Nov; 21(14):2018-31. PubMed ID: 25133793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
    Panda A; Gurusamy N; Rajasingh S; Carter HK; Thomas EL; Rajasingh J
    Differentiation; 2020; 112():58-66. PubMed ID: 31954271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells for cardiac repair.
    Zwi-Dantsis L; Gepstein L
    Cell Mol Life Sci; 2012 Oct; 69(19):3285-99. PubMed ID: 22960788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
    Budniatzky I; Gepstein L
    Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.
    Martins AM; Vunjak-Novakovic G; Reis RL
    Stem Cell Rev Rep; 2014 Apr; 10(2):177-90. PubMed ID: 24425421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: cell therapy and tissue engineering for cardiovascular disease.
    Haraguchi Y; Shimizu T; Yamato M; Okano T
    Stem Cells Transl Med; 2012 Feb; 1(2):136-41. PubMed ID: 23197760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.
    Oikonomopoulos A; Kitani T; Wu JC
    Mol Ther; 2018 Jul; 26(7):1624-1634. PubMed ID: 29699941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in Bioengineering Strategies for Heart Regenerative Medicine.
    Häneke T; Sahara M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
    Yamakawa H; Ieda M
    Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of selective cytotoxic viral vectors for concentration of undifferentiated cells in cardiomyocytes derived from human induced pluripotent stem cells.
    Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Mizuguchi H; Sato Y
    Sci Rep; 2019 Mar; 9(1):3630. PubMed ID: 30842516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy.
    Morita Y; Kishino Y; Fukuda K; Tohyama S
    Cell Prolif; 2022 Aug; 55(8):e13248. PubMed ID: 35534945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.
    Yang X; Pabon L; Murry CE
    Circ Res; 2014 Jan; 114(3):511-23. PubMed ID: 24481842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
    Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell therapy for cardiac regeneration: hits and misses.
    Padda J; Sequiera GL; Sareen N; Dhingra S
    Can J Physiol Pharmacol; 2015 Oct; 93(10):835-41. PubMed ID: 26443930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced regeneration--the progress and promise of direct reprogramming for heart repair.
    Addis RC; Epstein JA
    Nat Med; 2013 Jul; 19(7):829-36. PubMed ID: 23836233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy.
    Ichimura H; Shiba Y
    Circ J; 2017 Jun; 81(7):929-935. PubMed ID: 28603177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
    Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials.
    Prowse AB; Timmins NE; Yau TM; Li RK; Weisel RD; Keller G; Zandstra PW
    Can J Cardiol; 2014 Nov; 30(11):1335-49. PubMed ID: 25442434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.